Model Number 366594 |
Device Problems
Retraction Problem (1536); Defective Component (2292); Improper Flow or Infusion (2954)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/02/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
Oem manufacturer: the manufacturing location for this product is nipro.This site is an oem manufacturing site.Therefore, bd corporate headquarters in franklin lakes, nj has been listed in sections d.3.And g.1.And the franklin lakes fda registration number has been used for the manufacture report number.H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
|
Event Description
|
It was reported when using the bd microtainer® contact-activated lancet lancet did not activate, the needle was not recovered.This event occurred 200 times.The following information was provided by the initial reporter.The customer stated: "during using the lancet, it was found that the lancet did not activate, the needle was not recovery, and occurred insufficient blood flow issue.Patients and users were not affected.".
|
|
Event Description
|
It was reported when using the bd microtainer® contact-activated lancet lancet did not activate, the needle was not recovered.This event occurred 200 times.The following information was provided by the initial reporter.The customer stated: "during using the lancet, it was found that the lancet did not activate, the needle was not recovery, and occurred insufficient blood flow issue.Patients and users were not affected.".
|
|
Manufacturer Narrative
|
H.6.Investigation summary: material # 366594.Lot/batch # b7b82d4.Bd received 10 samples for investigation.The samples were evaluated by visual examination and functional testing and the indicated failure modes for does not activate/does not recover/insufficient blood flow with the incident lot was not observed.Additionally, retention samples from bd inventory were evaluated by visual examination and functional testing and no issues were observed relating to does not activate/does not recover/insufficient blood flow as all samples met specifications.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.There were no related quality issues during manufacturing of the product.This complaint is unable to be confirmed for the indicated failure modes.Bd was not able to identify a root cause for the indicated failure modes.Complaints received for this device and reported condition will continue to be tracked and trended.Our business team regularly reviews the collected data for identification of emerging trends.H3 other text : see h.10.
|
|
Search Alerts/Recalls
|